Enhanced hepatoprotective effects of empagliflozin and vitamin D dual therapy against metabolic dysfunction‐associated steatohepatitis in mice by boosted modulation of metabolic, oxidative stress, and inflammatory pathways DOI Open Access
Wesam F. Farrash, Shakir Idris,

Mohamed E. Elzubier

et al.

International Journal of Experimental Pathology, Journal Year: 2024, Volume and Issue: 105(6), P. 219 - 234

Published: Oct. 13, 2024

Although single treatment with sodium-glucose cotransporter-2 inhibitors (SGLT2i) or vitamin D

Language: Английский

Global research hotspots and trends in oxidative stress-related diabetic nephropathy: a bibliometric study DOI Creative Commons
Xiaorong Wang,

Wu Zeng,

Tingchao He

et al.

Frontiers in Endocrinology, Journal Year: 2025, Volume and Issue: 15

Published: Jan. 10, 2025

Oxidative stress is widely acknowledged as a key pathogenic mechanism in diabetic nephropathy (DN). In recent years, the role of oxidative DN has garnered increasing attention. However, no bibliometric analysis yet been conducted on relationship between and DN. This study aims to systematically analyze relevant literature, identify trends research, assess current hotspots, predict future directions. We retrieved literature related from Web Science Core Collection database. analyzed data publication volume, countries/regions, institutions, journals, keywords, other metrics using VOSviewer, Bibliometrix R package, CiteSpace. From 2014 2024, total 4076 publications were published across 755 showing consistent upward trend each year. China United States are leading contributors this field demonstrate close collaborative efforts. The top by country, institution, journal, author include: (1919 publications), Jilin University Central South (69 each), BIOMEDICINE & PHARMACOTHERAPY (117 Prof. Sun Lin (33 publications). most frequent keyword "oxidative stress" (3683 occurrences). co-citation analysis, Alicic RZ's 2017 was cited (144 citations). These findings highlight critical importance investigating pathogenesis perspective. demonstrates steady increase research since 2014, highlighting its central Future should focus molecular mechanisms explore therapeutic potential, provide new strategies for prevention treatment

Language: Английский

Citations

0

Update in non-alcoholic fatty liver disease management: role of sodium-glucose cotransporter 2 inhibitors DOI
Oscar René Zambrano-Vásquez, Fernando Cortés-Camacho, Jorge Ismael Castañeda‐Sánchez

et al.

Life Sciences, Journal Year: 2025, Volume and Issue: unknown, P. 123638 - 123638

Published: April 1, 2025

Language: Английский

Citations

0

Enhanced hepatoprotective effects of empagliflozin and vitamin D dual therapy against metabolic dysfunction‐associated steatohepatitis in mice by boosted modulation of metabolic, oxidative stress, and inflammatory pathways DOI Open Access
Wesam F. Farrash, Shakir Idris,

Mohamed E. Elzubier

et al.

International Journal of Experimental Pathology, Journal Year: 2024, Volume and Issue: 105(6), P. 219 - 234

Published: Oct. 13, 2024

Although single treatment with sodium-glucose cotransporter-2 inhibitors (SGLT2i) or vitamin D

Language: Английский

Citations

1